Llwytho...
An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus
PURPOSE OF REVIEW: SGLT2 inhibitors are the newest class of oral anti-hyperglycemic agents that have been approved for the treatment of diabetes mellitus. Over the past year there have been significant developments in both the safety and efficacy of this class of medications that are presented in th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6028052/ https://ncbi.nlm.nih.gov/pubmed/27898586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000311 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|